Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
AI confidence 59% · prior close shown (market closed)
ELI LILLY & Co shows accelerating business momentum based on AlphaOS pipeline evidence, with weak management execution.
Why it matters: Revenue +48% YoY in Q2 FY2026.
Watch: EPS significantly below estimate raises questions about near-term cost pressures or revenue timing.
3 signals not yet derived from pipeline evidence
What it means for the thesis — synthesis, not a raw event feed.
Pipeline evidence · 0d ago
Reported figures for ELI LILLY & Co — research only, not investment advice.
Theme: GLP-1 Franchise — Mounjaro & Zepbound
Updated
What happened recently for ELI LILLY & Co (LLY) — events, not interpretation.
Research & analysis only — not investment advice.
Prior close
$1,180.16
Market cap
$1.11T
Profitable
Yes
Revenue $65.18B
Net income
$20.64B
FY Dec 31, 2025
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for ELI LILLY & Co — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Follow ELI LILLY & Co through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.